Understanding highly adaptable cancer cells in lung adenocarcinoma
Determining the role and function of a high plasticity cell state in lung adenocarcinoma
This work explores how certain highly adaptable cancer cells contribute to lung adenocarcinoma growth and resistance to treatments.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11138420 on NIH RePORTER |
What this research studies
We are learning about special cancer cells in lung adenocarcinoma that can change their characteristics, which helps tumors grow and resist therapy. Our team first found these adaptable cells in mouse lung tumors and then confirmed their presence in human lung adenocarcinoma samples. We believe these cells are key drivers of cancer progression and treatment failure. By understanding how these cells work, we hope to find new ways to fight lung cancer.
Who could benefit from this research
Good fit: This foundational work focuses on understanding cancer biology and does not currently involve direct patient participation, but future clinical applications would target patients with lung adenocarcinoma.
Not a fit: Patients whose cancer does not involve this specific type of highly adaptable cell state may not directly benefit from therapies developed from this particular line of research.
Why it matters
Potential benefit: If successful, this work could lead to new treatment strategies that target these adaptable cancer cells, potentially improving outcomes for patients with lung adenocarcinoma.
How similar studies have performed: While the concept of tumor plasticity is recognized, this research aims to specifically define and target a newly identified high plasticity cell state in lung adenocarcinoma, representing a novel approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Chan, Jason Earl — Sloan-Kettering Inst Can Research
- Study coordinator: Chan, Jason Earl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.